Supranee Buranapraditkun

2.2k total citations
87 papers, 1.0k citations indexed

About

Supranee Buranapraditkun is a scholar working on Immunology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Supranee Buranapraditkun has authored 87 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 21 papers in Infectious Diseases and 20 papers in Pharmacology. Recurrent topics in Supranee Buranapraditkun's work include HIV Research and Treatment (18 papers), Drug-Induced Adverse Reactions (16 papers) and Immunotherapy and Immune Responses (12 papers). Supranee Buranapraditkun is often cited by papers focused on HIV Research and Treatment (18 papers), Drug-Induced Adverse Reactions (16 papers) and Immunotherapy and Immune Responses (12 papers). Supranee Buranapraditkun collaborates with scholars based in Thailand, United States and Netherlands. Supranee Buranapraditkun's co-authors include Jettanong Klaewsongkram, Sanipa Suradhat, Kiat Ruxrungtham, Nattiya Hirankarn, Wirach Maek-a-nantawat, Waranyoo Phoolcharoen, Sunee Sirivichayakul, Kaewta Rattanapisit, Eakachai Prompetchara and Prapaporn Pornsuriyasak and has published in prestigious journals such as Immunity, PLoS ONE and Journal of Virology.

In The Last Decade

Supranee Buranapraditkun

81 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Supranee Buranapraditkun Thailand 19 326 302 190 164 148 87 1.0k
M. Scot Roberts United States 19 389 1.2× 353 1.2× 51 0.3× 312 1.9× 49 0.3× 42 1.6k
Shiki Takamura Japan 26 322 1.0× 1.5k 4.9× 157 0.8× 353 2.2× 30 0.2× 53 2.1k
Nicole H. Lazarus United States 16 161 0.5× 946 3.1× 88 0.5× 204 1.2× 13 0.1× 22 1.7k
Annapurna Vyakarnam United Kingdom 23 444 1.4× 1.1k 3.7× 704 3.7× 291 1.8× 61 0.4× 71 1.9k
Carin E.G. Havenith Netherlands 20 202 0.6× 910 3.0× 447 2.4× 347 2.1× 13 0.1× 33 1.9k
Jiří Kovařík Switzerland 23 183 0.6× 802 2.7× 51 0.3× 290 1.8× 28 0.2× 53 1.7k
Gareth Brady Ireland 17 167 0.5× 1.2k 4.1× 111 0.6× 474 2.9× 37 0.3× 32 1.9k
J. Navarro Spain 21 258 0.8× 739 2.4× 295 1.6× 158 1.0× 14 0.1× 57 1.3k
Paul V. McGuirt United States 8 121 0.4× 84 0.3× 112 0.6× 80 0.5× 38 0.3× 11 874
Manthrasalam Rengaraju United States 8 118 0.4× 1.3k 4.4× 99 0.5× 165 1.0× 18 0.1× 10 1.7k

Countries citing papers authored by Supranee Buranapraditkun

Since Specialization
Citations

This map shows the geographic impact of Supranee Buranapraditkun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Supranee Buranapraditkun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Supranee Buranapraditkun more than expected).

Fields of papers citing papers by Supranee Buranapraditkun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Supranee Buranapraditkun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Supranee Buranapraditkun. The network helps show where Supranee Buranapraditkun may publish in the future.

Co-authorship network of co-authors of Supranee Buranapraditkun

This figure shows the co-authorship network connecting the top 25 collaborators of Supranee Buranapraditkun. A scholar is included among the top collaborators of Supranee Buranapraditkun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Supranee Buranapraditkun. Supranee Buranapraditkun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Buranapraditkun, Supranee, et al.. (2024). Effect of Particulate Matter 2.5 on Primary Gingival Keratinocyte and Human Gingival Fibroblast Cell Lines. European Journal of Dentistry. 19(2). 464–471.
3.
Pradubpongsa, Panitan, et al.. (2023). Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin D Supplementation in the Build-up Phase of House Dust Mite-Specific Immunotherapy. Allergy Asthma and Immunology Research. 15(3). 336–336. 4 indexed citations
4.
Gantner, Pierre, Supranee Buranapraditkun, Amélie Pagliuzza, et al.. (2023). HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections. Immunity. 56(3). 653–668.e5. 41 indexed citations
5.
Chongpison, Yuda, Sira Sriswasdi, Supranee Buranapraditkun, et al.. (2023). IFN-γ ELISpot-enabled machine learning for culprit drug identification in nonimmediate drug hypersensitivity. Journal of Allergy and Clinical Immunology. 153(1). 193–202. 6 indexed citations
6.
Buranapraditkun, Supranee, et al.. (2022). Immune-associated plasma proteins in oral and oropharyngeal cancer patients. Heliyon. 8(9). e10753–e10753. 2 indexed citations
7.
Khorattanakulchai, Narach, Kaewta Rattanapisit, Balamurugan Shanmugaraj, et al.. (2022). Plant-Produced S1 Subunit Protein of SARS-CoV-2 Elicits Immunogenic Responses in Mice. Vaccines. 10(11). 1961–1961. 5 indexed citations
8.
Sintusek, Palittiya, Supranee Buranapraditkun, Nawarat Posuwan, et al.. (2022). Safety and Immunogenicity of Standard and Double Doses of Hepatitis B Vaccine in Children after Liver Transplantation: An Open-Label, Randomised Controlled Trial. Vaccines. 10(1). 92–92. 2 indexed citations
9.
Puangsricharern, Vilavun, et al.. (2021). Clinical parameters and biological markers associated with acute severe ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis. Scientific Reports. 11(1). 20275–20275. 9 indexed citations
10.
Buranapraditkun, Supranee, et al.. (2020). Transcriptomic analysis of peripheral blood mononuclear cells in head and neck squamous cell carcinoma patients. Oral Diseases. 27(6). 1394–1402. 4 indexed citations
11.
Buranapraditkun, Supranee, et al.. (2020). Evaluation of lymphocyte apoptosis in patients with oral cancer. Journal of Applied Oral Science. 28. e20200124–e20200124. 7 indexed citations
12.
Chongpison, Yuda, et al.. (2019). Hypersensitivity reactions to antituberculosis drugs confirmed by interferon gamma enzyme-linked Immunospot assay. Journal of Allergy and Clinical Immunology. 143(2). AB26–AB26. 1 indexed citations
13.
Khow, Orawan, et al.. (2016). Anticancer properties of phospholipase A2 from Daboia siamensis venom on human skin melanoma cells. ˜The œJournal of venomous animals and toxins including tropical diseases. 22(1). 7–7. 18 indexed citations
14.
Tieu, Hong‐Van, Piyarat Suntarattiwong, Thanyawee Puthanakit, et al.. (2014). Comparing Interferon-Gamma Release Assays to Tuberculin Skin Test in Thai Children with Tuberculosis Exposure. PLoS ONE. 9(8). e105003–e105003. 12 indexed citations
15.
Sirivichayakul, Sunee, Pattarawat Thantiworasit, Supranee Buranapraditkun, et al.. (2011). Immunogenicity assay validation for an HIV vaccine trial: High IFNγ+/IL-2+ CD8+ T cells background in healthy Thais. Vaccine. 29(35). 6002–6007. 2 indexed citations
16.
Chang, Judy, Sunee Sirivichayakul, Anchalee Avihingsanon, et al.. (2009). Impaired Quality of the Hepatitis B Virus (HBV)-Specific T-Cell Response in Human Immunodeficiency Virus Type 1-HBV Coinfection. Journal of Virology. 83(15). 7649–7658. 35 indexed citations
17.
Maek-a-nantawat, Wirach, et al.. (2007). Increased Interleukin-17 Production Both in Helper T Cell Subset Th17 And CD4-Negative T Cells in Human Immunodeficiency Virus Infection. Viral Immunology. 20(1). 66–75. 66 indexed citations
18.
Ungsedhapand, Chaiwat, Eugène Kroon, Surapol Suwanagool, et al.. (2001). A Randomized, Open-Label, Comparative Trial of Zidovudine Plus Lamivudine Versus Zidovudine Plus Lamivudine Plus Didanosine in Antiretroviral-Naive HIV-1–Infected Thai Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(2). 116–123. 11 indexed citations
19.
Ruxrungtham, Kiat, Eugène Kroon, Chaiwat Ungsedhapand, et al.. (2000). A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients. AIDS. 14(10). 1375–1382. 23 indexed citations
20.
Ruxrungtham, Kiat, Surapol Suwanagool, Jorge A. Tavel, et al.. (2000). A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand. AIDS. 14(16). 2509–2513. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Scot Roberts Breakdown of academic impact, for papers by Shiki Takamura Breakdown of academic impact, for papers by Nicole H. Lazarus Breakdown of academic impact, for papers by Annapurna Vyakarnam Breakdown of academic impact, for papers by Carin E.G. Havenith Breakdown of academic impact, for papers by Jiří Kovařík Breakdown of academic impact, for papers by Gareth Brady Breakdown of academic impact, for papers by J. Navarro Breakdown of academic impact, for papers by Paul V. McGuirt Breakdown of academic impact, for papers by Manthrasalam Rengaraju
Rankless by CCL
2026